. 2016 May 14;22(18):4484–4500. doi: 10.3748/wjg.v22.i18.4484

Table 1.

Biochemical parameters of the different treatment groups

Group	ALT (U/L)	AST (U/L)	Bilirubin (mg/dL)	Albumin (g/L)	BUN (mmol/L)	Scr (μmol/L)
Control (n = 8)	43.3 ± 7.7	124 ± 14	0.3 ± 0.1	34.1 ± 3.4	8.7 ± 1.2	22.4 ± 4.0
OVX + CCl₄ (n = 6)	166 ± 10.1^a ^b	439 ± 19^a ^b	3.4 ± 0.3^a ^b	21.5 ± 2.8^a ^b	16.7 ± 1.8^a ^b	35.0 ± 4.7^a ^b
OVX + CCl₄ + DPN (n = 7)	86.1 ± 8.7^a	211 ± 15^a	1.7 ± 0.2^a	31.0 ± 3.3	9.6 ± 1.5	24.9 ± 4.5
OVX + CCl₄ + DPN + PHTPP (n = 6)	168 ± 10.2^a ^b	436 ± 23^a ^b	3.3 ± 0.4^a ^b	20.8 ± 2.0^a ^b	16.5 ± 2.1^a ^b	37.5 ± 4.6^a ^b

P < 0.05 vs control group;

P < 0.05 vs DPN group. OVX: Ovariectomized; SVR: Systemic vascular resistance; DPN: Diarylpropionitrile.